1. sayfa ve
Tekrarlanan kayıtlar tek bir kaynakta birleştirilmektedir.
1
Sunum

Sunum

Kaynak
:
Yazar(lar) :
Yıl :
2020
COVID-19 CORONAVIRUS (
COVID-
19) ile mücadele programı Prof.Dr.Mustafa TAYAR İşyerinizi
COVID-19a hazır hale getirme SIMULATION EXERCISE NOVEL CORONAVIRUS (
COVID Tuesday, October 27, 2020 SIMULATION EXERCISE NOVEL CORONAVIRUS (
COVID-
19) page 4 Coronavirüsten korunma yolları Tuesday, October 27, 2020 SIMULATION EXERCISE NOVEL CORONAVIRUS (
COVID-
19) page 5 Okullar için önemli hijyen noktaları Tuesday, October 27, 2020 SIMULATION EXERCISE NOVEL CORONAVIRUS (
COVID-
19) page COVID-19
2
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
COVID-19-associated encephalopathy: Neurological manifestation of COVID-19 Coronavirus disease 2019 (
COVID-
19) is a viral disease, also known as severe acute respiratory syndrome coronavirus 2, was first reported in Wuhan, China COVID-
19-associated neurological manifestations have not been widely reported. In this report, we describe a case of encephalopathy in a patient with
COVID-
19 infection. Covid-19
3
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
COVID-19 solution Some CoVs have recently entered humans from infected animals and lastly we have SARS
COVID-
19, (CoV), which causes severe acute, often fatal respiratory sars covid-19
4
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Why COVID-19? Covid-
19 has been estimated to have a case fatality rate of around 3%. In late December 2019, an outbreak of
COVID-
19 was reported from Wuhan city, China. Today
COVID-
19 has affected more than 212 countries and has made billions of people to be quarantined in their houses.
5
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Fighting COVID-19 Abstract The current
COVID-
19 pandemic caused by the novel coronavirus (SARS-CoV2) poses a threat to global health owing to its high rate of spread and covid-19
6
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Asymptomatic COVID-19 Infection Management: The Key to Stop COVID-19 The
COVID-
19 disease, emerged in December 2019, has spread rapidly, with new cases confirmed in multiple countries. portion of the population to virus and increase the late diagnosis and thereafter enhance
COVID-
19 mortality. Thereafter, it is fundamental to review our
COVID-
19 screening approach and enlarge
COVID-
19 testing to the general population by using rapid testing appliances COVID-19
7
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
COVID-19: Immunopathogenesis Coronavirus-
19 disease (
COVID-
19) first described in Wuhan, China at the end of 2019. respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks may help to elucidate the pathogenesis of
COVID -
19.
8
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
COVID 19: Neuromuscular manifestations COVID-
19 pandemic is ongoing and information on the neurological aspects of this viral infection is being gathered. This manuscript studies the available information on the neuromuscular manifestations of
COVID-
19. covid-19 neurological manifestations covid-19 neuromuscular manifestations
9
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
COVID-19 and hypertension
10
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Cannabinoids and COVID-19 involved in immune function, the effect of cannabinoid intake on infectious conditions is questioned for several years and is of particular interest in the
COVID 19 pandemia. covid-19
11
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Tobacco and COVID-19 Similar data have been approved found for coronavirus disease-2019 (
COVID-
19) pandemic. adverse effects of tobacco and tobacco products and to raise awareness among the public and to make efforts to smoking on every opportunity during the
COVID -
19 pandemic. covid-19
12
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
COVID-19: a review The enduring epidemic outbreak which started in Wuhan city of China, in December 2019 caused by the 2019 novel coronavirus (
COVID-
19) or the severe acute A highly virulent and pathogenic
COVID-
19 viral infection with incubation period ranging from two to fourteen days, transmitted by breathing of infected Approximately 1,016,128 reported cases, 211,615 recovered cases and 53,069 deaths of
COVID-2019 have been reported to date (April 2, 2020). COVID-19
13
Dergi Makalesi

Dergi Makalesi

Kaynak
1:
Kaynak
2:
Yazar(lar) :
Yıl :
2020
Pathogenesis of COVID-19 The coronavirus disease 2019 (
COVID-
19) is a very contagious infectious disease which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV The aim of this report is to review the immunopathogenesis of
COVID-
19 in the light of current literature. covid-19
14
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
COVID-19: Apocalypse Now?
15
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Covid-19 and Neurology Coronavirus disease-
19 (
COVID-
19) pandemic is a new and important burden for the neurological area. mechanisms of neurological involvement of the disease may be explained more efficiently by neurologists who are included within the multidisciplinary
COVID -
19 teams. covid-19
16
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
COVID-19 and epilepsy
17
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Coping with COVID-19 Antivirals, specifically Remdesivir has been a strong candidate for the treatment of
COVID-
19. However, it has yet to receive universal acceptance for the treatment of
COVID-
19. These findings suggest the hypothesis that anti-malarial drugs have efficacy in the treatment of
COVID-
19. COVID 19
18
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China Background: Faced with the coronavirus disease 2019 (
COVID-
19) pandemic, the development of
COVID-
19 vaccines has been progressing at an unprecedented of vaccines against
COVID-
19 during the pandemic. -
19 vaccination or valuing doctor’s recommendations could increase the probability of accepting
COVID-
19 vaccination as soon as possible, while having COVID-19
19
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Stand on the Same Side Against Covid – 19 Clinical Management of Covid-19 Covid-19
20
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
COVID-19 and lung pathology
21
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Hemophagocytic syndrome and COVID-19 The case of a woman hospitalized due to
COVID-
19 is presented.
22
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
COVID-19: immunopathogenesis and Immunotherapeutics Abstract The recent novel coronavirus disease (
COVID-
19) outbreak, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is seeing a Therefore, mechanisms underlying immune abnormalities in patients with
COVID-
19 must be elucidated to guide clinical management of the disease. strategies against
COVID-
19.
23
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
Nutrition, immunity and COVID-19 Gut dysbiosis is a feature of disease including many infectious diseases and has been described in
COVID-
19. This is seen in cases of severe
COVID-
19.
24
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Dergi:
Yayıncı:
Elsevier
Yazar(lar) :
Yıl :
2020
COVID-19 Testing
25
Dergi Makalesi

Dergi Makalesi
Kaynak
:
Yayıncı:
Elsevier
Yıl :
2020
COVID-19: endgames
26
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
Pharmacogenomics of COVID-19 therapies Abstract A new global pandemic of coronavirus disease 2019 (
COVID-
19) has resulted in high mortality and morbidity. In conclusion, although direct evidence in
COVID-
19 patients is lacking, we identified potential actionable genetic markers in
COVID-
19 therapies. Clinical studies in
COVID-
19 patients are deemed warranted to assess potential roles of these markers.
27
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
COVID-19 in hematological malignancies
28
Dergi Makalesi

Dergi Makalesi

Yazar(lar) :
Yıl :
2020
COVID-19 and our DNA covid-19
29
Dergi Makalesi

Dergi Makalesi

Dergi:
Yazar(lar) :
Yıl :
2020
COVID-19: Infection or Autoimmunity The clinical and laboratory features of
COVID-
19 are reviewed with attention to the immunologic manifestations of the disease. Recent
COVID-
19 publications describe a variety of clinical presentations including an asymptomatic state, pneumonia, a hemophagocytic lymphohistiocytosis -
19. COVID-19